...

Transforming global healthcare through strategic carve-out and joint venture formation

strategic carve-out and JV transformation in pharma

Related solution

Business transformation

We provide and deliver solutions to meet your goals. On time. On budget.
In a landmark three-part transaction, two of the world’s largest pharmaceutical companies embarked on a bold strategic transformation to sharpen focus and realign their business portfolios.
The deal, one of the most complex in the industry’s history, involved:

1. Combining both consumer healthcare divisions into a new, world-leading joint venture

2.Exchanging business units — one company divested its vaccines division in return for the other’s oncology business, aligning each organisation with its growth ambitions

3.Spinning off an animal health business to a third major pharmaceutical player through a separate deal

The scope of the transformation was immense, impacting:

The challenge

Our approach

The outcome

Why Helixr?

Helixr is a trusted partner in complex life sciences transformations. Our deep experience in carve-outs, integrations, and SAP-enabled restructuring allows us to confidently lead large-scale programmes from strategy through to execution.

We don’t just advise — we embed ourselves in your teams to drive delivery, manage risk, and ensure value is realised.

Neil Littlejohn

Founder & Executive Director

Connect with Helixr
Let’s have a conversation. Contact us to find out more about what we can do for you.